Ulenistamab

Ulenistamab (PBP1510) is a first-in-class hunamised IgG1 monoclonal antibody targeting pancreatic adenocarcinoma upregulated factor (PAUF) . Ulenistamab can be used for pancreatic cancer (PC) research[1].

Product Specifications

CAS Number

[2415259-90-2]

Product Name Alternative

PBP1510

UNSPSC

12352203

Target

Others

Type

Inhibitory Antibodies

Related Pathways

Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/ulenistamab.html

Purity

97.50

Solubility

10 mM in DMSO

Smiles

[Ulenistamab]

Molecular Weight

(147.35 kDa)

References & Citations

[1]Kedar Diwakar Mandakhalikar, et al. First-in-class monoclonal antibody (mAb) PBP1510 targeting pancreatic adenocarcinoma upregulated factor (PAUF) for pancreatic cancer (PC) treatment: Preclinical perspectives. Journal of Clinical Oncology 2022 40:16_suppl, e16274-e16274.